Virgin Olive Oil Slows Cognitive Decline by Reshaping the Gut Microbiome, Study Finds

Extra virgin olive oil has long been a cornerstone of the Mediterranean diet, but a new study published in Microbiome suggests its benefits extend well beyond cardiovascular protection. Researchers found that higher consumption of virgin olive oil was associated with measurable improvements in cognitive function over two years, and that changes in gut microbiota composition appear to help explain why. The catch: the more common, refined version of olive oil tells a very different story.

Virgin Olive Oil Linked to Two-Year Cognitive Gains

The study, led by Jiaqi Ni, Nancy Babio, Stephanie Nishi, and colleagues at Universitat Rovira i Virgili, tracked 656 adults aged 55 to 75 who were overweight or obese and had metabolic syndrome. All participants were enrolled in PREDIMED-Plus, an ongoing randomized controlled trial. Dietary intake was measured using validated semi-quantitative food frequency questionnaires, and neuropsychological tests were administered at baseline and again at the two-year follow-up.

Higher virgin olive oil (VOO) intake was associated with improvements across several cognitive domains: global cognition, executive function, attention, and language skills. Each additional 10g per day of VOO was linked to positive changes across those domains. In contrast, higher intake of common olive oil (COO), which typically contains refined or olive-pomace oil and carries far fewer bioactive compounds, was associated with lower gut microbial diversity and accelerated cognitive decline. Both oils share a similar fatty acid profile, but the difference in phenolic content appears to matter enormously.

This distinction reinforces what earlier systematic reviews on olive oil and cognitive performance have suggested: the type of olive oil, not just the amount, shapes outcomes. A meta-analysis on the Mediterranean diet and cognitive health similarly found that high adherence to the diet, which centers on extra virgin olive oil, was linked to lower risk of mild cognitive impairment and Alzheimer's disease in older adults.

Brain Health in Aging Populations Remains an Urgent Challenge

The stakes are substantial. Cognitive decline and dementia are among the most pressing public health concerns associated with aging. CDC data show that 4% of U.S. adults aged 65 and older reported a dementia diagnosis in 2022, with prevalence climbing sharply with age. Globally, cases are rising as populations age, and disease-modifying treatments remain limited. Dietary strategies that could slow the trajectory of decline before clinical dementia sets in are therefore of considerable interest.

As the study authors put it: "At a time when cases of cognitive decline and dementia are on the rise, our findings drive home the importance of improving diet quality, and in particular prioritizing extra virgin olive oil over other refined versions as an effective, simple and accessible strategy for protecting brain health."

The mechanisms likely involve multiple pathways. The paper notes that metabolic, vascular, and anti-inflammatory effects all probably contribute. But the gut microbiota findings add a layer of biological specificity that the researchers find particularly compelling.

Adlercreutzia and the Olive Oil-Gut-Brain Axis

VOO is extracted mechanically and retains high levels of phenolic compounds including hydroxytyrosol and oleuropein. These polyphenols are poorly absorbed in the small intestine, meaning they reach the colon largely intact, where gut bacteria can metabolize them. The study found that higher VOO intake was associated with a more diverse overall gut microbiota structure at baseline, while COO intake was linked to lower alpha diversity, a measure of the number and evenness of species in a microbial community.

The bacterium Adlercreutzia emerged as a potential mediator of the VOO-cognition link. This equol-producing genus has been associated with estrogen metabolism and anti-inflammatory activity, and the study data suggest it may help translate VOO's phenolic load into cognitive benefits. Meanwhile, Akkermansia, a genus often highlighted for its role in metabolic health, was negatively associated with changes in attention and inversely related to VOO consumption, a finding the authors flag as requiring further investigation.

This microbiome-mediated pathway is consistent with what researchers studying the gut-brain axis in neurodegenerative disease have described as a bidirectional system in which gut microbial signals feed back into brain function. Separately, research on EVOO polyphenols and Alzheimer's pathology has shown that these compounds can inhibit amyloid-beta aggregation and reduce neuroinflammation through multiple molecular targets, mechanisms that could amplify whatever benefits the microbiome pathway delivers.

Observational Design Limits Causal Claims

The study has important limitations. It is an observational analysis nested within a clinical trial, and dietary intake was self-reported using food frequency questionnaires, which carry inherent measurement error. Because the design is prospective but not interventional, causal inference is not possible. It remains unclear whether VOO drives the favorable microbial changes or whether people who happen to eat more VOO already have healthier guts for other reasons.

Stool samples were also collected only at baseline, which means the study captures gut microbiota composition at a single point rather than tracking how it shifts alongside dietary changes over the two-year follow-up. The population was also specific: middle-aged to older adults with overweight, obesity, and metabolic syndrome, so the findings may not generalize to healthier or younger cohorts. The authors call for high-quality clinical studies to confirm the results and clarify efficacy.

Next Steps Toward Microbiome-Based Nutrition Strategies

Despite those caveats, the paper makes a persuasive case that distinguishing between VOO and COO in both research and nutrition guidelines matters more than current practice acknowledges. Mean total olive oil intake in the study ranged from 30g to 58g per day across different intake tertiles, quantities typical of Mediterranean eating patterns but well above what most people outside that region consume.

The finding that a specific microbial genus may mediate VOO's cognitive benefits opens a practical path forward. If researchers can confirm which bacterial taxa are driving the effect, it could point toward targeted microbiome-based interventions designed to preserve cognitive function in aging populations, whether through diet, probiotics, or precision nutrition approaches. For now, the study adds meaningful weight to a straightforward recommendation: when it comes to olive oil and brain health, the grade of the oil appears to be as important as the amount.